Results 51 to 60 of about 70,104,016 (248)

Retrospective Analysis of Donor Lymphocyte Infusions in Pediatric Patients With Mixed Chimerism After Hematopoietic Stem Cell Transplantation

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is an essential therapy for several malignant and nonmalignant diseases, but relapse and graft loss remain the principal threats to its success. Routine monitoring of chimerism and minimal residual disease (MRD) enables early detection of imminent recurrence and guides ...
Carmen Junk, Sebastian Michaelis, Michaela Döring, Thomas Eichholz, Ursula Holzer, Martin Ebinger, Tim Flaadt, Rupert Handgretinger, Peter Lang, Jan Frederic Weller, Markus Mezger   +10 more
wiley   +1 more source

Researcher Perspectives on Obstacles and Facilitators of Open Scholarship at a Canadian University

Partnership: The Canadian Journal of Library and Information Practice and Research
In 2022, researchers at Dalhousie University were surveyed to assess their understanding and practice of open scholarship. The survey was designed to answer these primary questions: what are Dalhousie University researchers' existing practices and ...
Melissa Rothfus
doaj   +1 more source

Awareness and use of open research practices: an international survey of researchers across disciplinesAwareness and use of open research practices: an international survey of researchers across disciplines [PDF]

Royal Society Open Science
This mixed methods study investigates international researchers' awareness and use of open research practices and explores variations across regions, disciplines, methodologies and career stages.
Charlotte Rebecca Pennington, Emma Norris, Magda Skubera, Yalige Ba, Ryssa Moffat, Olavo B. Amaral, Matúš Adamkovič, Arca Adıgüzel, Rafaela A. Almeida, Jessie R. Baldwin, Nick Ballou, Luiza Marques Prates Behrens, Michael G. Bertram, Ingvild E. Bjerke, Simon E. Blackwell, Agata Bochynska, Michiel R. De Boer, Ivan Buljan, Cristian B. Canales-Aguirre, Harry Carey, Vladimira Čavojová, William P. Cawthorn, Simon Christ, Krzysztof Cipora, Alden Conner, Federica P. Conte, Davide Crepaldi, David A. Ellis, Timothy M. Errington, Emily K. Farran, Gordon B. Feld, Raquel Freitag, Paulina Gebauer, Sarah Gunn, Helena Hartmann, Victoria C. Hellon, Gabriela Hofer, Malika Ihle, Ayumi Ikeda, Andrew Jones, Vanessa A. Jorge, Yusuph A. Kafula, Tamara Kalandadze, Veli-Matti Karhulahti, Halil E. Kocalar, Malgorzata Lagisz, Margherita Lanz, Félix P. Leiva, Marco Tullio Liuzza, Marcel Martončik, Hiroshi Matsui, Maria Montefinese, David Moreau, David P. Morgan, Shinichi Nakagawa, Helen Niemeyer, Gustav Nilsonne, Carmen Penido, Sofia Persson, Elena Serena Piccardi, Rima-Maria Rahal, Jakub Rajčáni, Ben Ridley, Michele Scandola, Felix D. Schönbrodt, Sandy Schumann, Mojtaba Soltanlou, James Steele, Suzanne L. K. Stewart, Eli S. J. Thoré, Luka Ursić, Michelangelo Vianello, Vootele Voikar, Nicholas C. Wu, Yuki Yamada, Cemre Yilmaz, Naoto Yoshimura, Mircea Zloteanu, Marija F. Žuljević, Marcus R. Munafo, Kait Clark   +80 more
doaj   +1 more source

Peculiarities of Integrating Mechanical Valves in Microfluidic Channels Using Direct Laser Writing

Applied Bionics and Biomechanics, 2022
Regenerative medicine is a fast expanding scientific topic. One of the main areas of development directions in this field is the usage of additive manufacturing to fabricate functional components that would be later integrated directly into the human ...
Lucero Hernandez-Cedillo, Deividas Andriukaitis, Lukas Šerpytis, Tomas Drevinskas, Olga Kornyšova, Vilma Kaškonienė, Mantas Stankevičius, Kristina Bimbiraitė-Survilienė, Audrius Sigitas Maruška, Linas Jonušauskas   +9 more
doaj   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source

The Impact of the COVID‐19 Pandemic on Childhood Cancer Survival: A Population‐Based Assessment of Survival Patterns Between 2015 and 2023 in Germany

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Numerous international studies have reported declines in new cancer diagnoses, delayed diagnoses and disruptions in cancer treatment following the implementation of COVID‐19 pandemic public health measures, raising concerns that these effects may ultimately contribute to increased cancer mortality.
Friederike Erdmann, Maike Wellbrock, Javier Louro, Arndt Borkhardt, Martin Schrappe, Claudia Trübenbach, Desiree Grabow, Cécile M. Ronckers, Joachim Schüz   +8 more
wiley   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye, Chimezie Okwuonu, Evelyn Idam, Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Zinnah Aloziem, Blossom Amamchukwu, Patience Elimia, Mkpoikanabasi Obot‐Obot, Henry Mbakwe, Praises Maduagwuna, Olatunji Akinrodoye, Chiamaka Anyanwu, Benjamin Anyanwu, Adedamola Akinsiku, Oluwatoyin A. Akinsiku, Muzamil O. Hassan, Fatiu A. Arogundade, Olalekan E. Ojo, Homayemem Weli, Jesupelumi Adenihun, Aderemi Adelaja, Ebun Bamgboye, Olalekan Olatise, Ade E. Faponle, Ayoola Odeyemi, Michael Muoka, Stephen Asaolu, Qudrat Busari, Blessing Dawudu, Michael Naiyeju, Rasheed A. Balogun   +33 more
wiley   +1 more source

The Role of Open Science in Our Research

BioResources
This editorial considers Open Science, what it is, what are its potential benefits, what are the pillars of engagement upon which it rests, and what are some of the main challenges facing its further adoption by research communities.
Angeles Blanco
doaj   +2 more sources

Cataloguing and theorising open research practices in the arts, humanities and social sciences: Problematising and diversifying ‘Open Science’ [version 1; peer review: 2 approved, 1 approved with reservations]

F1000Research
Background Discourses of ‘Open Science’ have been criticised for privileging the quantitative and positivist methodologies of science, technology, engineering and mathematics (STEM) research at the expense of qualitative, interpretive, critical ...
Miranda Barnes, Jenni Adams, Samuel Moore, Stephen Pinfield   +3 more
doaj   +1 more source

An enhanced version of FREM (Fracture Risk Evaluation Model) using national administrative health data: analysis protocol for development and validation of a multivariable prediction model

Diagnostic and Prognostic Research, 2023
Background Osteoporosis poses a growing healthcare challenge owing to its rising prevalence and a significant treatment gap, as patients are widely underdiagnosed and consequently undertreated, leaving them at high risk of osteoporotic fracture.
Simon Bang Kristensen, Anne Clausen, Michael Kriegbaum Skjødt, Jens Søndergaard, Bo Abrahamsen, Sören Möller, Katrine Hass Rubin   +6 more
doaj   +1 more source